AI assistant
Pulmonx Corp — Director's Dealing 2024
Mar 6, 2024
34428_dirs_2024-03-05_ec6092fe-deb2-42e0-9463-ceebd566af7e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2024-03-01
Reporting Person: Lehman David Aaron (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-01 | Common Stock | S | 459 | $9.06 | Disposed | 149380 | Direct |
| 2024-03-01 | Common Stock | S | 809 | $9.06 | Disposed | 148571 | Direct |
| 2024-03-01 | Common Stock | S | 3083 | $9.06 | Disposed | 145488 | Direct |
| 2024-03-01 | Common Stock | A | 34500 | — | Acquired | 179988 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-03-01 | Employee Stock Option (right to buy) | $9.30 | A | 69100 | Acquired | 2034-02-28 | Common Stock (69100) | Direct |
Footnotes
F1: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021.
F2: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022.
F3: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.
F4: Represents grant of RSUs payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2024.
F5: The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2024.